sitem-insel AG

learn@lunch - June 2020



June 25, 2020


Online via Zoom

Rethinking Drug Design with Artificial Intelligence - Prof. Dr. Gisbert Schneider, ETH Zürich


Prof. Dr. Gisbert Schneider, MD

Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich

12:15 - 13:00

Prof. Schneider’s research activities focus on the development and application of adaptive intelligent systems for molecular de novo design and drug discovery,